Amgen Total Current Assets from 2010 to 2026

AMG Stock  EUR 329.30  11.55  3.63%   
Amgen Total Current Assets yearly trend continues to be very stable with very little volatility. Total Current Assets are likely to drop to about 24.2 B. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
First Reported
2019-03-31
Previous Quarter
27.9 B
Current Value
29.1 B
Quarterly Volatility
8.3 B
 
Covid
 
Interest Hikes
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.
Evaluating Amgen's Total Current Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.

Latest Amgen's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Amgen Inc over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Amgen's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
   Total Current Assets   
       Timeline  

Amgen Total Current Assets Regression Statistics

Arithmetic Mean35,467,778,824
Geometric Mean33,502,526,438
Coefficient Of Variation32.64
Mean Deviation10,582,822,422
Median37,618,000,000
Standard Deviation11,577,352,513
Sample Variance134035091.2T
Range31B
R-Value(0.78)
Mean Square Error56075364.4T
R-Squared0.61
Significance0.0002
Slope(1,787,367,843)
Total Sum of Squares2144561459.3T

Amgen Total Current Assets History

202624.2 B
202529.1 B
202429 B
202330.3 B
202222.2 B
202119.4 B
202021.1 B

About Amgen Financial Statements

Amgen investors utilize fundamental indicators, such as Total Current Assets, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Current Assets29.1 B24.2 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock:
Check out the analysis of Amgen Correlation against competitors.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Understanding that Amgen's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Amgen represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Amgen's market price signifies the transaction level at which participants voluntarily complete trades.